CAR-T cell therapy cost effective for paediatric B-cell ALL?
- 6 Downloads
- Sarkar RR, et al. Cost-Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia. Journal of the National Cancer Institute : 14 Dec 2018. Available from: URL: http://doi.org/10.1093/jnci/djy193
© Springer Nature Switzerland AG 2019